Manzo Pharmaceuticals, Inc. (MNZO)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 13, 2026
Market Cap1.10K
Revenue (ttm)n/a
Net Income (ttm)7.75M
Shares Out1.10B
EPS (ttm)1.91
PE Ratio0.00
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,364,000
Average Volume335,213
Open0.0000
Previous Closen/a
Day's Range0.0000 - 0.0000
52-Week Range0.0000 - 0.0001
Beta-112.46
RSI43.32
Earnings Daten/a

About Manzo Pharmaceuticals

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporat... [Read more]

Sector Financials
Founded 1980
Employees 12
Stock Exchange OTCMKTS
Ticker Symbol MNZO
Full Company Profile